SLP
Overvalued by 24.9% based on the discounted cash flow analysis.
Market cap | $912.31 Million |
---|---|
Enterprise Value | $803.81 Million |
Dividend Yield | $0.1794 (0.39%) |
Earnings per Share | $0.52 |
Beta | 0.0 |
Outstanding Shares | 19,984,945 |
Avg 30 Day Volume | 145,958 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 86.75 |
---|---|
PEG | -2497.34 |
Price to Sales | 15.44 |
Price to Book Ratio | 5.79 |
Enterprise Value to Revenue | 12.43 |
Enterprise Value to EBIT | 87.23 |
Enterprise Value to Net Income | 76 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and...